Jianting Long

Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial

Yunpeng Yang, Song Qu, Jingao Li et al. · The Lancet Oncology · 2021 · 429 citations

Medicine, Clinical Trials, Immune Checkpoint Inhibitor +8

METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma

Manling Huang, Jianting Long, Zhijia Yao et al. · Cancer Research · 2022 · 174 citations · Full text

Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer

Meihua Qu, Ruifang Zeng, Shi Fang et al. · International Journal of Pharmaceutics · 2014 · 126 citations

Nanomedicine, Liposome-based Co-delivery, Polymer-drug Conjugate +10

miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β

Heping Li, Xiancheng Zeng, Bing Zhang et al. · Carcinogenesis · 2013 · 95 citations

Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling

Jianting Long, Chunlin Jiang, Baoxian Liu et al. · Cancer Letters · 2017 · 86 citations

Medicine, Liver Physiology, Hepatocellular Carcinoma Cells +12